Trevena (TRVN) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

TRVN Stock Forecast


Trevena stock forecast is as follows: a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

TRVN Analyst Ratings


Buy

According to 2 Wall Street analysts, Trevena's rating consensus is 'Buy'. The analyst rating breakdown for TRVN stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
May 16, 2024H.C. WainwrightBuyBuyHold
Apr 02, 2024JMP SecuritiesMarket OutperformMarket OutperformHold
Row per page
Go to

Trevena's last stock rating was published by H.C. Wainwright on May 16, 2024. The company gave TRVN a "Buy" rating, the same as its previous rate.

Trevena Financial Forecast


Trevena Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Mar 18Mar 16Mar 15Mar 14
Revenue--------$180.00K-$6.00K-$-438.00K-$20.00K$208.00K$181.00K$178.00K$209.00K$69.00K$3.00M-$1.88M$625.00K-
Avg Forecast$3.00M$152.60K$177.51K$206.49K$240.19K$279.39K$325.00K$143.50K$100.00K$100.00K$50.00K$467.33K$436.75K$230.00K$565.25K$459.00K$705.50K$1.13M$781.60K$225.00K$1.50M$1.46M$1.71M$681.82K$101.43K
High Forecast$3.00M$152.60K$177.51K$206.49K$240.19K$279.39K$325.00K$143.50K$100.00K$100.00K$50.00K$467.33K$436.75K$230.00K$565.25K$459.00K$705.50K$1.13M$781.60K$225.00K$1.50M$1.75M$2.06M$818.18K$121.72K
Low Forecast$3.00M$152.60K$177.51K$206.49K$240.19K$279.39K$325.00K$143.50K$100.00K$100.00K$50.00K$467.33K$436.75K$230.00K$565.25K$459.00K$705.50K$1.13M$781.60K$225.00K$1.50M$1.17M$1.37M$545.45K$81.14K
# Analysts1111111111111111111548151112
Surprise %--------1.80%-0.12%--1.00%-0.04%0.45%0.26%0.16%0.27%0.31%2.00%-1.09%0.92%-

Trevena's average Quarter revenue forecast for Dec 23 based on 1 analysts is $143.50K, with a low forecast of $143.50K, and a high forecast of $143.50K. TRVN's average Quarter revenue forecast represents a -20.28% decrease compared to the company's last Quarter revenue of $180.00K (Sep 23).

Trevena EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Mar 18Mar 16Mar 15Mar 14
# Analysts1111111111111111111548151112
EBITDA--------$-8.30M-$-10.12M$-9.35M$-15.47M$-14.55M$-16.36M$92.05K$-13.66M$-13.92M$-9.73M$-11.76M$-5.14M$-8.17M$-17.28M$-12.81M$-9.27M
Avg Forecast$-1.80M$-91.56K$-106.51K$-123.89K$-144.11K$-167.64K$-195.00K$-86.10K$-60.00K$-60.00K$-30.00K$-280.40K$-262.05K$-138.00K$-339.15K$-275.40K$-423.30K$-676.50K$-12.17M$-135.00K$-900.00K$-12.95M$-15.66M$-13.87M$-19.10M
High Forecast$-1.80M$-91.56K$-106.51K$-123.89K$-144.11K$-167.64K$-195.00K$-86.10K$-60.00K$-60.00K$-30.00K$-280.40K$-262.05K$-138.00K$-339.15K$-275.40K$-423.30K$-676.50K$-9.73M$-135.00K$-900.00K$-10.36M$-12.53M$-11.10M$-15.28M
Low Forecast$-1.80M$-91.56K$-106.51K$-123.89K$-144.11K$-167.64K$-195.00K$-86.10K$-60.00K$-60.00K$-30.00K$-280.40K$-262.05K$-138.00K$-339.15K$-275.40K$-423.30K$-676.50K$-14.60M$-135.00K$-900.00K$-15.54M$-18.79M$-16.65M$-22.92M
Surprise %--------138.42%-337.30%33.33%59.05%105.43%48.23%-0.33%32.28%20.57%0.80%87.13%5.71%0.63%1.10%0.92%0.49%

1 analysts predict TRVN's average Quarter EBITDA for Mar 22 to be $-339.15K, with a high of $-339.15K and a low of $-339.15K. This is -468.45% lower than Trevena's previous annual EBITDA (Dec 21) of $92.05K.

Trevena Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Mar 18Mar 16Mar 15Mar 14
# Analysts1111111111111111111548151112
Net Income--------$-7.93M-$-5.96M$-7.46M$-14.84M$-15.15M$-16.32M$-13.95K$-13.77M$-14.02M$-9.84M$-11.87M$-5.55M$-9.02M$-17.78M$-12.93M$-9.37M
Avg Forecast$-2.34M$-4.48M$-4.69M$-5.54M$-6.61M$-6.61M$-8.63M$-8.10M$-3.20M$-22.38M$-20.96M$-37.16M$-45.30M$-54.63M$-46.63M$-53.30M$-47.97M$-39.97M$-12.30M$-31.98M$-22.65M$-12.30M$-16.11M$-14.01M$-18.75M
High Forecast$-2.34M$-4.48M$-4.69M$-5.54M$-6.61M$-6.61M$-8.63M$-8.10M$-3.20M$-22.38M$-20.96M$-37.16M$-45.30M$-54.63M$-46.63M$-53.30M$-47.97M$-39.97M$-9.84M$-31.98M$-22.65M$-9.84M$-12.89M$-11.21M$-15.00M
Low Forecast$-2.34M$-4.48M$-4.69M$-5.54M$-6.61M$-6.61M$-8.63M$-8.10M$-3.20M$-22.38M$-20.96M$-37.16M$-45.30M$-54.63M$-46.63M$-53.30M$-47.97M$-39.97M$-14.76M$-31.98M$-22.65M$-14.76M$-19.33M$-16.81M$-22.50M
Surprise %--------2.48%-0.28%0.20%0.33%0.28%0.35%0.00%0.29%0.35%0.80%0.37%0.25%0.73%1.10%0.92%0.50%

Trevena's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. TRVN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Trevena SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Mar 18Mar 16Mar 15Mar 14
# Analysts1111111111111111111548151112
SG&A--------$4.57M-$6.09M$5.72M$7.68M$10.31M$11.01M$9.76K$10.44M$10.54M$7.37M$8.23M$4.09M$5.07M$3.92M$3.09M$2.02M
Avg Forecast$253.88M$12.91M$15.02M$17.47M$20.33M$23.64M$27.50M$12.14M$8.46M$8.46M$4.23M$39.55M$36.96M$19.46M$47.84M$38.84M$59.70M$95.42M$66.14M$19.04M$126.94M$123.41M$145.07M$57.70M$8.58M
High Forecast$253.88M$12.91M$15.02M$17.47M$20.33M$23.64M$27.50M$12.14M$8.46M$8.46M$4.23M$39.55M$36.96M$19.46M$47.84M$38.84M$59.70M$95.42M$66.14M$19.04M$126.94M$148.09M$174.09M$69.24M$10.30M
Low Forecast$253.88M$12.91M$15.02M$17.47M$20.33M$23.64M$27.50M$12.14M$8.46M$8.46M$4.23M$39.55M$36.96M$19.46M$47.84M$38.84M$59.70M$95.42M$66.14M$19.04M$126.94M$98.73M$116.06M$46.16M$6.87M
Surprise %--------0.54%-1.44%0.14%0.21%0.53%0.23%0.00%0.17%0.11%0.11%0.43%0.03%0.04%0.03%0.05%0.24%

Trevena's average Quarter SG&A projection for Dec 23 is $12.14M, based on 1 Wall Street analysts, with a range of $12.14M to $12.14M. The forecast indicates a 165.61% rise compared to TRVN last annual SG&A of $4.57M (Sep 23).

Trevena EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Mar 18Mar 16Mar 15Mar 14
# Analysts1111111111111111111548151112
EPS--------$-0.57-$-0.62$-0.78$-2.17$-2.29$-2.46$-0.00$-2.09$-2.15$-1.53$-1.88$-0.96$-3.49$-8.66$-8.24$-14.62
Avg Forecast$-2.75$-5.25$-5.50$-6.50$-7.75$-7.75$-10.13$-9.50$-3.75$-26.25$-24.58$-43.58$-53.13$-64.06$-54.69$-62.50$-56.25$-46.88$-50.00$-37.50$-26.56$-0.30$-0.29$-0.39$-0.68
High Forecast$-2.75$-5.25$-5.50$-6.50$-7.75$-7.75$-10.13$-9.50$-3.75$-26.25$-24.58$-43.58$-53.13$-64.06$-54.69$-62.50$-56.25$-46.88$-50.00$-37.50$-26.56$-0.24$-0.23$-0.31$-0.54
Low Forecast$-2.75$-5.25$-5.50$-6.50$-7.75$-7.75$-10.13$-9.50$-3.75$-26.25$-24.58$-43.58$-53.13$-64.06$-54.69$-62.50$-56.25$-46.88$-50.00$-37.50$-26.56$-0.36$-0.35$-0.47$-0.82
Surprise %--------0.15%-0.03%0.02%0.04%0.04%0.04%0.00%0.04%0.05%0.03%0.05%0.04%11.64%29.85%21.12%21.51%

According to undefined Wall Street analysts, Trevena's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to TRVN previous annual EPS of $NaN (undefined).

Trevena Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
VSTMVerastem$3.90$8.33113.59%Buy
TRVNTrevena$1.69$3.50107.10%-
LPCNLipocine$6.09$10.0064.20%Buy
NBRVNabriva Therapeutics$1.42$1.00-29.58%-
VTVTvTv Therapeutics$14.00$5.00-64.29%Buy

TRVN Forecast FAQ


Yes, according to 2 Wall Street analysts, Trevena (TRVN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of TRVN's total ratings.

Trevena's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $844.58K (high $844.58K, low $844.58K), average EBITDA is $-507K (high $-507K, low $-507K), average net income is $-21.851M (high $-21.851M, low $-21.851M), average SG&A $71.47M (high $71.47M, low $71.47M), and average EPS is $-25.625 (high $-25.625, low $-25.625). TRVN's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.54M (high $3.54M, low $3.54M), average EBITDA is $-2.122M (high $-2.122M, low $-2.122M), average net income is $-17.054M (high $-17.054M, low $-17.054M), average SG&A $299.29M (high $299.29M, low $299.29M), and average EPS is $-20 (high $-20, low $-20).

Based on Trevena's last annual report (Dec 2022), the company's revenue was $-418K, which missed the average analysts forecast of $1.7M by -124.60%. Apple's EBITDA was $-56.375M, beating the average prediction of $-1.02M by 5429.13%. The company's net income was $-53.667M, missing the average estimation of $-184M by -70.79%. Apple's SG&A was $34.73M, missing the average forecast of $143.81M by -75.85%. Lastly, the company's EPS was $-7.59, missing the average prediction of $-215 by -96.48%. In terms of the last quarterly report (Sep 2023), Trevena's revenue was $180K, beating the average analysts' forecast of $100K by 80.00%. The company's EBITDA was $-8.305M, beating the average prediction of $-60K by 13741.67%. Trevena's net income was $-7.93M, beating the average estimation of $-3.198M by 147.99%. The company's SG&A was $4.57M, missing the average forecast of $8.46M by -45.97%. Lastly, the company's EPS was $-0.57, missing the average prediction of $-3.75 by -84.80%